| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.31 | 4e-10 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-08 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-07 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.24 | 9e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |